Will the public take a universal influenza vaccine?: the need for social and behavioral science research.

Clicks: 377
ID: 71646
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Every influenza season, uptake of the flu vaccine falls short of the Healthy People 2020 goal of at least 70% of adults being vaccinated. Mixed methods research finds multiple factors associated with this phenomenon including misconceptions about the vaccine, skepticism about an annual vaccine, concerns about efficacy and safety, lack of knowledge, perceived risk, among others. The national goal to develop, test and produce an effective universal influenza vaccine requires a significant scientific and financial investment in research. However, there is no true investment in the social and behavioral science research necessary to ensure that once a universal vaccine is available, the public will take that new vaccine. This article highlights some qualitative and quantitative research results to provide some understanding of the challenges to increasing vaccine uptake. We also identify research questions necessary to ensure adoption of new universal vaccines.
Reference Key
crouse-quinn2019willhuman Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Crouse Quinn, Sandra;Jamison, Amelia;
Journal human vaccines & immunotherapeutics
Year 2019
DOI
10.1080/21645515.2019.1698245
URL
Keywords
trust perceived risk universal influenza vaccine vaccine hesitancy patient-provider communication vaccine acceptance

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.